Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
What is Mauna Kea Technologies SA stock price today?▼
The current price of MKTBS.PA is €0.08 EUR — it has decreased by -5.95% in the past 24 hours. Watch Mauna Kea Technologies SA stock price performance more closely on the chart.
What is Mauna Kea Technologies SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mauna Kea Technologies SA stocks are traded under the ticker MKTBS.PA.
What is Mauna Kea Technologies SA market cap?▼
Today Mauna Kea Technologies SA has the market capitalization of 6.3M
What is Mauna Kea Technologies SA revenue for the last year?▼
Mauna Kea Technologies SA revenue for the last year amounts to 15.31M EUR.
What is Mauna Kea Technologies SA net income for the last year?▼
MKTBS.PA net income for the last year is -20.81M EUR.
How many employees does Mauna Kea Technologies SA have?▼
As of April 22, 2026, the company has 87 employees.
In which sector is Mauna Kea Technologies SA located?▼
Mauna Kea Technologies SA operates in the Health & Wellness sector.
When did Mauna Kea Technologies SA complete a stock split?▼
Mauna Kea Technologies SA has not had any recent stock splits.
Where is Mauna Kea Technologies SA headquartered?▼
Mauna Kea Technologies SA is headquartered in Paris, France.